サンプル依頼リスト カート
  • English
デフォルト表紙
市場調査レポート
商品コード
1800081

経口コレラ・ワクチンの世界市場：市場レポート、競合分析、地域別機会 (2025年～2031年)

Global Oral Cholera Vaccine Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031

出版日
発行
QYResearch
ページ情報
英文 79 Pages
納期
2～3営業日
カスタマイズ可能
適宜更新あり
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=148.28円
経口コレラ・ワクチンの世界市場：市場レポート、競合分析、地域別機会 (2025年～2031年)
出版日: 2025年08月29日
発行: QYResearch
ページ情報: 英文 79 Pages
納期: 2～3営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 図表
  • 目次
概要

当レポートは、経口コレラ・ワクチン (Oral Cholera Vaccine) 市場について調査しており、市場規模や動向・需要の予測、成長要因および課題の分析、タイプ・用途・企業・地域別の内訳、競合情勢、主要企業のプロファイルなどの情報を提供しています。

目次

第1章 市場の事業概要

  • 経口コレラ・ワクチン 製品範囲
  • 経口コレラ・ワクチン タイプ別
    • 世界の経口コレラ・ワクチン 販売：タイプ別 (2020 & 2024 & 2031)
    • Euvichol-Plus
    • DUKORAL
    • Shanchol
    • Others
  • 経口コレラ・ワクチン 用途別
    • 世界の経口コレラ・ワクチン 売上 比較：用途別 (2020 & 2024 & 2031)
    • Preventive Campaigns
    • Outbreak Response
  • 世界の経口コレラ・ワクチン 市場 推定および予測 (2020-2031)
    • 世界の経口コレラ・ワクチン 市場規模 in 価格 成長率 (2020-2031)
    • Global Oral Cholera Vaccine Market Size in Volume Growth Rate (2020-2031)
    • Global Oral Cholera Vaccine Price Trends (2020-2031)
  • 前提条件と制限

第2章 市場規模と予測：地域別

  • 世界の経口コレラ・ワクチン 市場規模：地域別: 2020 VS 2024 VS 2031
  • 世界の経口コレラ・ワクチン 過去の市場分析：地域別 (2020-2025)
    • 世界の経口コレラ・ワクチンの販売市場シェア 地域別 (2020-2025)
    • 世界の経口コレラ・ワクチンの収益市場シェア 地域別 (2020-2025)
  • 世界の経口コレラ・ワクチン 市場 推定および予測 地域別 (2026-2031)
    • 世界の経口コレラ・ワクチン 売上予測・予想 地域別 (2026-2031)
    • 世界の経口コレラ・ワクチンの収益予測：地域別 (2026-2031)
  • 主要地域と新興市場分析
    • 北米の経口コレラ・ワクチン 市場規模および予測 (2020-2031)
    • 欧州の経口コレラ・ワクチン 市場規模および予測 (2020-2031)
    • 中国の経口コレラ・ワクチン 市場規模および予測 (2020-2031)
    • インド 経口コレラ・ワクチン 市場規模および予測 (2020-2031)
    • 韓国 経口コレラ・ワクチン 市場規模および予測 (2020-2031)
    • ベトナム 経口コレラ・ワクチン 市場規模および予測 (2020-2031)

第3章 世界の市場規模：タイプ別

  • 世界の経口コレラ・ワクチンの過去の市場概要：タイプ別 (2020-2025)
    • 世界の経口コレラ・ワクチン 販売：タイプ別 (2020-2025)
    • 世界の経口コレラ・ワクチン 収益：タイプ別 (2020-2025)
    • 世界の経口コレラ・ワクチン 価格：タイプ別 (2020-2025)
  • 世界の経口コレラ・ワクチンの市場 推定および予測：タイプ別 (2026-2031)
    • 世界の経口コレラ・ワクチンの販売予測：タイプ別 (2026-2031)
    • 世界の経口コレラ・ワクチンの収益予測：タイプ別 (2026-2031)
    • 世界の経口コレラ・ワクチンの価格予測：タイプ別 (2026-2031)
  • 各種タイプ 経口コレラ・ワクチン 代表的な企業

第4章 世界の市場規模：用途別

  • 世界の経口コレラ・ワクチンの過去の市場概要：用途別 (2020-2025)
    • 世界の経口コレラ・ワクチン 販売：用途別 (2020-2025)
    • 世界の経口コレラ・ワクチン 収益：用途別 (2020-2025)
    • 世界の経口コレラ・ワクチン 価格：用途別 (2020-2025)
  • 世界の経口コレラ・ワクチン 市場 推定および予測：用途別 (2026-2031)
    • 世界の経口コレラ・ワクチンの販売予測：用途別 (2026-2031)
    • 世界の経口コレラ・ワクチンの収益予測：用途別 (2026-2031)
    • 世界の経口コレラ・ワクチンの価格予測：用途別 (2026-2031)
  • 新たな成長源 経口コレラ・ワクチン アプリケーション

第5章 競合他社の状況

  • 世界の経口コレラ・ワクチン 売上 ：競合別 (2020-2025)
  • 世界の経口コレラ・ワクチンの上位企業：収益別 (2020-2025)
  • 世界の経口コレラ・ワクチンの市場シェア：企業タイプ別 (Tier 1, Tier 2, and Tier 3) & (収益ベース 経口コレラ・ワクチン 2024年)
  • 世界の経口コレラ・ワクチン 企業別平均価格 (2020-2025)
  • 世界の主要メーカー 経口コレラ・ワクチン, 製造拠点 & 本社
  • 世界の主要メーカー 経口コレラ・ワクチン, 製品の種類・用途
  • 世界の主要メーカー 経口コレラ・ワクチン, 業界参入時期
  • 企業のM&A, 拡張計画

第6章 地域分析

  • 北米の市場: 参入企業、セグメント、下流、主要顧客
    • 北米の経口コレラ・ワクチン 売上：企業別
    • 北米の経口コレラ・ワクチン 売上 内訳 タイプ別 (2020-2025)
    • 北米の経口コレラ・ワクチン 売上構成比：用途別 (2020-2025)
    • 北米の経口コレラ・ワクチン 主要顧客
    • 北米の市場 トレンドと機会
  • 欧州の市場: 参入企業、セグメント、下流、主要顧客
    • 欧州の経口コレラ・ワクチン 売上：企業別
    • 欧州の経口コレラ・ワクチン 売上 内訳 タイプ別 (2020-2025)
    • 欧州の経口コレラ・ワクチン 売上構成比：用途別 (2020-2025)
    • 欧州の経口コレラ・ワクチン 主要顧客
    • 欧州の市場 トレンドと機会
  • 中国の市場: 参入企業、セグメント、下流、主要顧客
    • 中国の経口コレラ・ワクチン 売上：企業別
    • 中国の経口コレラ・ワクチン 売上 内訳 タイプ別 (2020-2025)
    • 中国の経口コレラ・ワクチン 売上構成比：用途別 (2020-2025)
    • 中国の経口コレラ・ワクチン 主要顧客
    • 中国の市場 トレンドと機会
  • インド 市場: 参入企業、セグメント、下流、主要顧客
    • インド 経口コレラ・ワクチン 売上：企業別
    • インド 経口コレラ・ワクチン 売上 内訳 タイプ別 (2020-2025)
    • インド 経口コレラ・ワクチン 売上構成比：用途別 (2020-2025)
    • インド 経口コレラ・ワクチン 主要顧客
    • インド 市場 トレンドと機会
  • 韓国 市場: 参入企業、セグメント、下流、主要顧客
    • 韓国 経口コレラ・ワクチン 売上：企業別
    • 韓国 経口コレラ・ワクチン 売上 内訳 タイプ別 (2020-2025)
    • 韓国 経口コレラ・ワクチン 売上構成比：用途別 (2020-2025)
    • 韓国 経口コレラ・ワクチン 主要顧客
    • 韓国 市場 トレンドと機会
  • ベトナム 市場: 参入企業、セグメント、下流、主要顧客
    • ベトナム 経口コレラ・ワクチン 売上：企業別
    • ベトナム 経口コレラ・ワクチン 売上 内訳 タイプ別 (2020-2025)
    • ベトナム 経口コレラ・ワクチン 売上構成比：用途別 (2020-2025)
    • ベトナム 経口コレラ・ワクチン 主要顧客
    • ベトナム 市場 トレンドと機会

第7章 企業概要と主要企業

  • PaxVax
  • Sanofi
  • Valneva
  • EuBiologics
  • United Biotech
  • Vabiotech
  • PaxVax

第8章 経口コレラ・ワクチン 製造コスト分析

  • 経口コレラ・ワクチン 主要原材料の分析
    • 主要原材料
    • 原材料の主な調達先
  • 製造コスト構成比
  • 製造工程分析： 経口コレラ・ワクチン
  • 経口コレラ・ワクチン 産業チェーン分析

第9章 マーケティングチャネル, 販売店と顧客

  • マーケティングチャネル
  • 経口コレラ・ワクチン 販売代理店一覧
  • 経口コレラ・ワクチン 顧客

第10章 経口コレラ・ワクチン 市場動向

  • 経口コレラ・ワクチン 業界動向
  • 経口コレラ・ワクチン 市場の促進要因
  • 経口コレラ・ワクチン 市場の課題
  • 経口コレラ・ワクチン 市場の抑制要因

第11章 市場調査結果と結論

第12章 付録

図表

List of Tables

Table 1. Global Oral Cholera Vaccine Sales (US$ Million) Growth Rate by Type (2020 & 2024 & 2031)

Table 2. Global Oral Cholera Vaccine Sales (US$ Million) Comparison by Application (2020 & 2024 & 2031)

Table 3. Global Market Oral Cholera Vaccine Market Size (US$ Million) by Region:2020 VS 2024 VS 2031

Table 4. Global Oral Cholera Vaccine Sales (K Units) by Region (2020-2025)

Table 5. Global Oral Cholera Vaccine Sales Market Share by Region (2020-2025)

Table 6. Global Oral Cholera Vaccine Revenue (US$ Million) Market Share by Region (2020-2025)

Table 7. Global Oral Cholera Vaccine Revenue Share by Region (2020-2025)

Table 8. Global Oral Cholera Vaccine Sales (K Units) Forecast by Region (2026-2031)

Table 9. Global Oral Cholera Vaccine Sales Market Share Forecast by Region (2026-2031)

Table 10. Global Oral Cholera Vaccine Revenue (US$ Million) Forecast by Region (2026-2031)

Table 11. Global Oral Cholera Vaccine Revenue Share Forecast by Region (2026-2031)

Table 12. Global Oral Cholera Vaccine Sales by Type (K Units) & (2020-2025)

Table 13. Global Oral Cholera Vaccine Sales Share by Type (2020-2025)

Table 14. Global Oral Cholera Vaccine Revenue by Type (US$ Million) & (2020-2025)

Table 15. Global Oral Cholera Vaccine Price by Type (US$/Unit) & (2020-2025)

Table 16. Global Oral Cholera Vaccine Sales by Type (K Units) & (2026-2031)

Table 17. Global Oral Cholera Vaccine Revenue by Type (US$ Million) & (2026-2031)

Table 18. Global Oral Cholera Vaccine Price by Type (US$/Unit) & (2026-2031)

Table 19. Representative Players of Each Type

Table 20. Global Oral Cholera Vaccine Sales by Application (K Units) & (2020-2025)

Table 21. Global Oral Cholera Vaccine Sales Share by Application (2020-2025)

Table 22. Global Oral Cholera Vaccine Revenue by Application (US$ Million) & (2020-2025)

Table 23. Global Oral Cholera Vaccine Price by Application (US$/Unit) & (2020-2025)

Table 24. Global Oral Cholera Vaccine Sales by Application (K Units) & (2026-2031)

Table 25. Global Oral Cholera Vaccine Revenue Market Share by Application (US$ Million) & (2026-2031)

Table 26. Global Oral Cholera Vaccine Price by Application (US$/Unit) & (2026-2031)

Table 27. New Sources of Growth in Oral Cholera Vaccine Application

Table 28. Global Oral Cholera Vaccine Sales by Company (K Units) & (2020-2025)

Table 29. Global Oral Cholera Vaccine Sales Share by Company (2020-2025)

Table 30. Global Oral Cholera Vaccine Revenue by Company (US$ Million) & (2020-2025)

Table 31. Global Oral Cholera Vaccine Revenue Share by Company (2020-2025)

Table 32. Global Oral Cholera Vaccine by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Oral Cholera Vaccine as of 2024)

Table 33. Global Market Oral Cholera Vaccine Average Price by Company (US$/Unit) & (2020-2025)

Table 34. Global Key Manufacturers of Oral Cholera Vaccine, Manufacturing Sites & Headquarters

Table 35. Global Key Manufacturers of Oral Cholera Vaccine, Product Type & Application

Table 36. Global Key Manufacturers of Oral Cholera Vaccine, Date of Enter into This Industry

Table 37. Manufacturers Mergers & Acquisitions, Expansion Plans

Table 38. North America Oral Cholera Vaccine Sales by Company (2020-2025) & (K Units)

Table 39. North America Oral Cholera Vaccine Sales Market Share by Company (2020-2025)

Table 40. North America Oral Cholera Vaccine Revenue by Company (2020-2025) & (US$ Million)

Table 41. North America Oral Cholera Vaccine Revenue Market Share by Company (2020-2025)

Table 42. North America Oral Cholera Vaccine Sales by Type (2020-2025) & (K Units)

Table 43. North America Oral Cholera Vaccine Sales Market Share by Type (2020-2025)

Table 44. North America Oral Cholera Vaccine Sales by Application (2020-2025) & (K Units)

Table 45. North America Oral Cholera Vaccine Sales Market Share by Application (2020-2025)

Table 46. Europe Oral Cholera Vaccine Sales by Company (2020-2025) & (K Units)

Table 47. Europe Oral Cholera Vaccine Sales Market Share by Company (2020-2025)

Table 48. Europe Oral Cholera Vaccine Revenue by Company (2020-2025) & (US$ Million)

Table 49. Europe Oral Cholera Vaccine Revenue Market Share by Company (2020-2025)

Table 50. Europe Oral Cholera Vaccine Sales by Type (2020-2025) & (K Units)

Table 51. Europe Oral Cholera Vaccine Sales Market Share by Type (2020-2025)

Table 52. Europe Oral Cholera Vaccine Sales by Application (2020-2025) & (K Units)

Table 53. Europe Oral Cholera Vaccine Sales Market Share by Application (2020-2025)

Table 54. China Oral Cholera Vaccine Sales by Company (2020-2025) & (K Units)

Table 55. China Oral Cholera Vaccine Sales Market Share by Company (2020-2025)

Table 56. China Oral Cholera Vaccine Revenue by Company (2020-2025) & (US$ Million)

Table 57. China Oral Cholera Vaccine Revenue Market Share by Company (2020-2025)

Table 58. China Oral Cholera Vaccine Sales by Type (2020-2025) & (K Units)

Table 59. China Oral Cholera Vaccine Sales Market Share by Type (2020-2025)

Table 60. China Oral Cholera Vaccine Sales by Application (2020-2025) & (K Units)

Table 61. China Oral Cholera Vaccine Sales Market Share by Application (2020-2025)

Table 62. India Oral Cholera Vaccine Sales by Company (2020-2025) & (K Units)

Table 63. India Oral Cholera Vaccine Sales Market Share by Company (2020-2025)

Table 64. India Oral Cholera Vaccine Revenue by Company (2020-2025) & (US$ Million)

Table 65. India Oral Cholera Vaccine Revenue Market Share by Company (2020-2025)

Table 66. India Oral Cholera Vaccine Sales by Type (2020-2025) & (K Units)

Table 67. India Oral Cholera Vaccine Sales Market Share by Type (2020-2025)

Table 68. India Oral Cholera Vaccine Sales by Application (2020-2025) & (K Units)

Table 69. India Oral Cholera Vaccine Sales Market Share by Application (2020-2025)

Table 70. South Korea Oral Cholera Vaccine Sales by Company (2020-2025) & (K Units)

Table 71. South Korea Oral Cholera Vaccine Sales Market Share by Company (2020-2025)

Table 72. South Korea Oral Cholera Vaccine Revenue by Company (2020-2025) & (US$ Million)

Table 73. South Korea Oral Cholera Vaccine Revenue Market Share by Company (2020-2025)

Table 74. South Korea Oral Cholera Vaccine Sales by Type (2020-2025) & (K Units)

Table 75. South Korea Oral Cholera Vaccine Sales Market Share by Type (2020-2025)

Table 76. South Korea Oral Cholera Vaccine Sales by Application (2020-2025) & (K Units)

Table 77. South Korea Oral Cholera Vaccine Sales Market Share by Application (2020-2025)

Table 78. Vietnam Oral Cholera Vaccine Sales by Company (2020-2025) & (K Units)

Table 79. Vietnam Oral Cholera Vaccine Sales Market Share by Company (2020-2025)

Table 80. Vietnam Oral Cholera Vaccine Revenue by Company (2020-2025) & (US$ Million)

Table 81. Vietnam Oral Cholera Vaccine Revenue Market Share by Company (2020-2025)

Table 82. Vietnam Oral Cholera Vaccine Sales by Type (2020-2025) & (K Units)

Table 83. Vietnam Oral Cholera Vaccine Sales Market Share by Type (2020-2025)

Table 84. Vietnam Oral Cholera Vaccine Sales by Application (2020-2025) & (K Units)

Table 85. Vietnam Oral Cholera Vaccine Sales Market Share by Application (2020-2025)

Table 86. PaxVax Company Information

Table 87. PaxVax Description and Business Overview

Table 88. PaxVax Oral Cholera Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 89. PaxVax Oral Cholera Vaccine Product

Table 90. PaxVax Recent Development

Table 91. Sanofi Company Information

Table 92. Sanofi Description and Business Overview

Table 93. Sanofi Oral Cholera Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 94. Sanofi Oral Cholera Vaccine Product

Table 95. Sanofi Recent Development

Table 96. Valneva Company Information

Table 97. Valneva Description and Business Overview

Table 98. Valneva Oral Cholera Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 99. Valneva Oral Cholera Vaccine Product

Table 100. Valneva Recent Development

Table 101. EuBiologics Company Information

Table 102. EuBiologics Description and Business Overview

Table 103. EuBiologics Oral Cholera Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 104. EuBiologics Oral Cholera Vaccine Product

Table 105. EuBiologics Recent Development

Table 106. United Biotech Company Information

Table 107. United Biotech Description and Business Overview

Table 108. United Biotech Oral Cholera Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 109. United Biotech Oral Cholera Vaccine Product

Table 110. United Biotech Recent Development

Table 111. Vabiotech Company Information

Table 112. Vabiotech Description and Business Overview

Table 113. Vabiotech Oral Cholera Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 114. Vabiotech Oral Cholera Vaccine Product

Table 115. Vabiotech Recent Development

Table 116. PaxVax Company Information

Table 117. PaxVax Description and Business Overview

Table 118. PaxVax Oral Cholera Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 119. PaxVax Oral Cholera Vaccine Product

Table 120. PaxVax Recent Development

Table 121. Production Base and Market Concentration Rate of Raw Material

Table 122. Key Suppliers of Raw Materials

Table 123. Oral Cholera Vaccine Distributors List

Table 124. Oral Cholera Vaccine Customers List

Table 125. Oral Cholera Vaccine Market Trends

Table 126. Oral Cholera Vaccine Market Drivers

Table 127. Oral Cholera Vaccine Market Challenges

Table 128. Oral Cholera Vaccine Market Restraints

Table 129. Research Programs/Design for This Report

Table 130. Key Data Information from Secondary Sources

Table 131. Key Data Information from Primary Sources

List of Figures

Figure 1. Oral Cholera Vaccine Product Picture

Figure 2. Global Oral Cholera Vaccine Sales (US$ Million) by Type (2020 & 2024 & 2031)

Figure 3. Global Oral Cholera Vaccine Sales Market Share by Type in 2024 & 2031

Figure 4. Euvichol-Plus Product Picture

Figure 5. DUKORAL Product Picture

Figure 6. Shanchol Product Picture

Figure 7. Others Product Picture

Figure 8. Global Oral Cholera Vaccine Sales (US$ Million) by Application (2020 & 2024 & 2031)

Figure 9. Global Oral Cholera Vaccine Sales Market Share by Application in 2024 & 2031

Figure 10. Preventive Campaigns Examples

Figure 11. Outbreak Response Examples

Figure 12. Global Oral Cholera Vaccine Sales, (US$ Million), 2020 VS 2024 VS 2031

Figure 13. Global Oral Cholera Vaccine Sales Growth Rate (2020-2031) & (US$ Million)

Figure 14. Global Oral Cholera Vaccine Sales (K Units) Growth Rate (2020-2031)

Figure 15. Global Oral Cholera Vaccine Price Trends Growth Rate (2020-2031) & (US$/Unit)

Figure 16. Oral Cholera Vaccine Report Years Considered

Figure 17. Global Market Oral Cholera Vaccine Market Size (US$ Million) by Region:2020 VS 2024 VS 2031

Figure 18. Global Oral Cholera Vaccine Revenue Market Share by Region: 2020 VS 2024

Figure 19. North America Oral Cholera Vaccine Revenue (US$ Million) Growth Rate (2020-2031)

Figure 20. North America Oral Cholera Vaccine Sales (K Units) Growth Rate (2020-2031)

Figure 21. Europe Oral Cholera Vaccine Revenue (US$ Million) Growth Rate (2020-2031)

Figure 22. Europe Oral Cholera Vaccine Sales (K Units) Growth Rate (2020-2031)

Figure 23. China Oral Cholera Vaccine Revenue (US$ Million) Growth Rate (2020-2031)

Figure 24. China Oral Cholera Vaccine Sales (K Units) Growth Rate (2020-2031)

Figure 25. India Oral Cholera Vaccine Revenue (US$ Million) Growth Rate (2020-2031)

Figure 26. India Oral Cholera Vaccine Sales (K Units) Growth Rate (2020-2031)

Figure 27. South Korea Oral Cholera Vaccine Revenue (US$ Million) Growth Rate (2020-2031)

Figure 28. South Korea Oral Cholera Vaccine Sales (K Units) Growth Rate (2020-2031)

Figure 29. Vietnam Oral Cholera Vaccine Revenue (US$ Million) Growth Rate (2020-2031)

Figure 30. Vietnam Oral Cholera Vaccine Sales (K Units) Growth Rate (2020-2031)

Figure 31. Global Oral Cholera Vaccine Revenue Share by Type (2020-2025)

Figure 32. Global Oral Cholera Vaccine Sales Share by Type (2026-2031)

Figure 33. Global Oral Cholera Vaccine Revenue Share by Type (2026-2031)

Figure 34. Global Oral Cholera Vaccine Revenue Share by Application (2020-2025)

Figure 35. Global Oral Cholera Vaccine Revenue Growth Rate by Application in 2020 & 2024

Figure 36. Global Oral Cholera Vaccine Sales Share by Application (2026-2031)

Figure 37. Global Oral Cholera Vaccine Revenue Share by Application (2026-2031)

Figure 38. Global Oral Cholera Vaccine Sales Share by Company (2024)

Figure 39. Global Oral Cholera Vaccine Revenue Share by Company (2024)

Figure 40. Global 5 Largest Oral Cholera Vaccine Players Market Share by Revenue in Oral Cholera Vaccine: 2020 & 2024

Figure 41. Oral Cholera Vaccine Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024

Figure 42. Manufacturing Cost Structure of Oral Cholera Vaccine

Figure 43. Manufacturing Process Analysis of Oral Cholera Vaccine

Figure 44. Oral Cholera Vaccine Industrial Chain

Figure 45. Channels of Distribution (Direct Vs Distribution)

Figure 46. Distributors Profiles

Figure 47. Bottom-up and Top-down Approaches for This Report

Figure 48. Data Triangulation

Figure 49. Key Executives Interviewed

目次

This research report focuses on the Oral Cholera Vaccine Market. It analyzes market size, trends and demand forecasts, as well as growth factors and challenges. The report provides market data breakdowns by type, application, company, and region, in addition to competitive landscape and key company profiles.

TABLE OF CONTENTS

1 Market Overview

  • 1.1 Oral Cholera Vaccine Product Scope
  • 1.2 Oral Cholera Vaccine by Type
    • 1.2.1 Global Oral Cholera Vaccine Sales by Type (2020 & 2024 & 2031)
    • 1.2.2 Euvichol-Plus
    • 1.2.3 DUKORAL
    • 1.2.4 Shanchol
    • 1.2.5 Others
  • 1.3 Oral Cholera Vaccine by Application
    • 1.3.1 Global Oral Cholera Vaccine Sales Comparison by Application (2020 & 2024 & 2031)
    • 1.3.2 Preventive Campaigns
    • 1.3.3 Outbreak Response
  • 1.4 Global Oral Cholera Vaccine Market Estimates and Forecasts (2020-2031)
    • 1.4.1 Global Oral Cholera Vaccine Market Size in Value Growth Rate (2020-2031)
    • 1.4.2 Global Oral Cholera Vaccine Market Size in Volume Growth Rate (2020-2031)
    • 1.4.3 Global Oral Cholera Vaccine Price Trends (2020-2031)
  • 1.5 Assumptions and Limitations

2 Market Size and Prospective by Region

  • 2.1 Global Oral Cholera Vaccine Market Size by Region: 2020 VS 2024 VS 2031
  • 2.2 Global Oral Cholera Vaccine Retrospective Market Scenario by Region (2020-2025)
    • 2.2.1 Global Oral Cholera Vaccine Sales Market Share by Region (2020-2025)
    • 2.2.2 Global Oral Cholera Vaccine Revenue Market Share by Region (2020-2025)
  • 2.3 Global Oral Cholera Vaccine Market Estimates and Forecasts by Region (2026-2031)
    • 2.3.1 Global Oral Cholera Vaccine Sales Estimates and Forecasts by Region (2026-2031)
    • 2.3.2 Global Oral Cholera Vaccine Revenue Forecast by Region (2026-2031)
  • 2.4 Major Region and Emerging Market Analysis
    • 2.4.1 North America Oral Cholera Vaccine Market Size and Prospective (2020-2031)
    • 2.4.2 Europe Oral Cholera Vaccine Market Size and Prospective (2020-2031)
    • 2.4.3 China Oral Cholera Vaccine Market Size and Prospective (2020-2031)
    • 2.4.4 India Oral Cholera Vaccine Market Size and Prospective (2020-2031)
    • 2.4.5 South Korea Oral Cholera Vaccine Market Size and Prospective (2020-2031)
    • 2.4.6 Vietnam Oral Cholera Vaccine Market Size and Prospective (2020-2031)

3 Global Market Size by Type

  • 3.1 Global Oral Cholera Vaccine Historic Market Review by Type (2020-2025)
    • 3.1.1 Global Oral Cholera Vaccine Sales by Type (2020-2025)
    • 3.1.2 Global Oral Cholera Vaccine Revenue by Type (2020-2025)
    • 3.1.3 Global Oral Cholera Vaccine Price by Type (2020-2025)
  • 3.2 Global Oral Cholera Vaccine Market Estimates and Forecasts by Type (2026-2031)
    • 3.2.1 Global Oral Cholera Vaccine Sales Forecast by Type (2026-2031)
    • 3.2.2 Global Oral Cholera Vaccine Revenue Forecast by Type (2026-2031)
    • 3.2.3 Global Oral Cholera Vaccine Price Forecast by Type (2026-2031)
  • 3.3 Different Types Oral Cholera Vaccine Representative Players

4 Global Market Size by Application

  • 4.1 Global Oral Cholera Vaccine Historic Market Review by Application (2020-2025)
    • 4.1.1 Global Oral Cholera Vaccine Sales by Application (2020-2025)
    • 4.1.2 Global Oral Cholera Vaccine Revenue by Application (2020-2025)
    • 4.1.3 Global Oral Cholera Vaccine Price by Application (2020-2025)
  • 4.2 Global Oral Cholera Vaccine Market Estimates and Forecasts by Application (2026-2031)
    • 4.2.1 Global Oral Cholera Vaccine Sales Forecast by Application (2026-2031)
    • 4.2.2 Global Oral Cholera Vaccine Revenue Forecast by Application (2026-2031)
    • 4.2.3 Global Oral Cholera Vaccine Price Forecast by Application (2026-2031)
  • 4.3 New Sources of Growth in Oral Cholera Vaccine Application

5 Competition Landscape by Players

  • 5.1 Global Oral Cholera Vaccine Sales by Players (2020-2025)
  • 5.2 Global Top Oral Cholera Vaccine Players by Revenue (2020-2025)
  • 5.3 Global Oral Cholera Vaccine Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Oral Cholera Vaccine as of 2024)
  • 5.4 Global Oral Cholera Vaccine Average Price by Company (2020-2025)
  • 5.5 Global Key Manufacturers of Oral Cholera Vaccine, Manufacturing Sites & Headquarters
  • 5.6 Global Key Manufacturers of Oral Cholera Vaccine, Product Type & Application
  • 5.7 Global Key Manufacturers of Oral Cholera Vaccine, Date of Enter into This Industry
  • 5.8 Manufacturers Mergers & Acquisitions, Expansion Plans

6 Region Analysis

  • 6.1 North America Market: Players, Segments, Downstream and Major Customers
    • 6.1.1 North America Oral Cholera Vaccine Sales by Company
      • 6.1.1.1 North America Oral Cholera Vaccine Sales by Company (2020-2025)
      • 6.1.1.2 North America Oral Cholera Vaccine Revenue by Company (2020-2025)
    • 6.1.2 North America Oral Cholera Vaccine Sales Breakdown by Type (2020-2025)
    • 6.1.3 North America Oral Cholera Vaccine Sales Breakdown by Application (2020-2025)
    • 6.1.4 North America Oral Cholera Vaccine Major Customer
    • 6.1.5 North America Market Trend and Opportunities
  • 6.2 Europe Market: Players, Segments, Downstream and Major Customers
    • 6.2.1 Europe Oral Cholera Vaccine Sales by Company
      • 6.2.1.1 Europe Oral Cholera Vaccine Sales by Company (2020-2025)
      • 6.2.1.2 Europe Oral Cholera Vaccine Revenue by Company (2020-2025)
    • 6.2.2 Europe Oral Cholera Vaccine Sales Breakdown by Type (2020-2025)
    • 6.2.3 Europe Oral Cholera Vaccine Sales Breakdown by Application (2020-2025)
    • 6.2.4 Europe Oral Cholera Vaccine Major Customer
    • 6.2.5 Europe Market Trend and Opportunities
  • 6.3 China Market: Players, Segments, Downstream and Major Customers
    • 6.3.1 China Oral Cholera Vaccine Sales by Company
      • 6.3.1.1 China Oral Cholera Vaccine Sales by Company (2020-2025)
      • 6.3.1.2 China Oral Cholera Vaccine Revenue by Company (2020-2025)
    • 6.3.2 China Oral Cholera Vaccine Sales Breakdown by Type (2020-2025)
    • 6.3.3 China Oral Cholera Vaccine Sales Breakdown by Application (2020-2025)
    • 6.3.4 China Oral Cholera Vaccine Major Customer
    • 6.3.5 China Market Trend and Opportunities
  • 6.4 India Market: Players, Segments, Downstream and Major Customers
    • 6.4.1 India Oral Cholera Vaccine Sales by Company
      • 6.4.1.1 India Oral Cholera Vaccine Sales by Company (2020-2025)
      • 6.4.1.2 India Oral Cholera Vaccine Revenue by Company (2020-2025)
    • 6.4.2 India Oral Cholera Vaccine Sales Breakdown by Type (2020-2025)
    • 6.4.3 India Oral Cholera Vaccine Sales Breakdown by Application (2020-2025)
    • 6.4.4 India Oral Cholera Vaccine Major Customer
    • 6.4.5 India Market Trend and Opportunities
  • 6.5 South Korea Market: Players, Segments, Downstream and Major Customers
    • 6.5.1 South Korea Oral Cholera Vaccine Sales by Company
      • 6.5.1.1 South Korea Oral Cholera Vaccine Sales by Company (2020-2025)
      • 6.5.1.2 South Korea Oral Cholera Vaccine Revenue by Company (2020-2025)
    • 6.5.2 South Korea Oral Cholera Vaccine Sales Breakdown by Type (2020-2025)
    • 6.5.3 South Korea Oral Cholera Vaccine Sales Breakdown by Application (2020-2025)
    • 6.5.4 South Korea Oral Cholera Vaccine Major Customer
    • 6.5.5 South Korea Market Trend and Opportunities
  • 6.6 Vietnam Market: Players, Segments, Downstream and Major Customers
    • 6.6.1 Vietnam Oral Cholera Vaccine Sales by Company
      • 6.6.1.1 Vietnam Oral Cholera Vaccine Sales by Company (2020-2025)
      • 6.6.1.2 Vietnam Oral Cholera Vaccine Revenue by Company (2020-2025)
    • 6.6.2 Vietnam Oral Cholera Vaccine Sales Breakdown by Type (2020-2025)
    • 6.6.3 Vietnam Oral Cholera Vaccine Sales Breakdown by Application (2020-2025)
    • 6.6.4 Vietnam Oral Cholera Vaccine Major Customer
    • 6.6.5 Vietnam Market Trend and Opportunities

7 Company Profiles and Key Figures

  • 7.1 PaxVax
    • 7.1.1 PaxVax Company Information
    • 7.1.2 PaxVax Business Overview
    • 7.1.3 PaxVax Oral Cholera Vaccine Sales, Revenue and Gross Margin (2020-2025)
    • 7.1.4 PaxVax Oral Cholera Vaccine Products Offered
    • 7.1.5 PaxVax Recent Development
  • 7.2 Sanofi
    • 7.2.1 Sanofi Company Information
    • 7.2.2 Sanofi Business Overview
    • 7.2.3 Sanofi Oral Cholera Vaccine Sales, Revenue and Gross Margin (2020-2025)
    • 7.2.4 Sanofi Oral Cholera Vaccine Products Offered
    • 7.2.5 Sanofi Recent Development
  • 7.3 Valneva
    • 7.3.1 Valneva Company Information
    • 7.3.2 Valneva Business Overview
    • 7.3.3 Valneva Oral Cholera Vaccine Sales, Revenue and Gross Margin (2020-2025)
    • 7.3.4 Valneva Oral Cholera Vaccine Products Offered
    • 7.3.5 Valneva Recent Development
  • 7.4 EuBiologics
    • 7.4.1 EuBiologics Company Information
    • 7.4.2 EuBiologics Business Overview
    • 7.4.3 EuBiologics Oral Cholera Vaccine Sales, Revenue and Gross Margin (2020-2025)
    • 7.4.4 EuBiologics Oral Cholera Vaccine Products Offered
    • 7.4.5 EuBiologics Recent Development
  • 7.5 United Biotech
    • 7.5.1 United Biotech Company Information
    • 7.5.2 United Biotech Business Overview
    • 7.5.3 United Biotech Oral Cholera Vaccine Sales, Revenue and Gross Margin (2020-2025)
    • 7.5.4 United Biotech Oral Cholera Vaccine Products Offered
    • 7.5.5 United Biotech Recent Development
  • 7.6 Vabiotech
    • 7.6.1 Vabiotech Company Information
    • 7.6.2 Vabiotech Business Overview
    • 7.6.3 Vabiotech Oral Cholera Vaccine Sales, Revenue and Gross Margin (2020-2025)
    • 7.6.4 Vabiotech Oral Cholera Vaccine Products Offered
    • 7.6.5 Vabiotech Recent Development
  • 7.7 PaxVax
    • 7.7.1 PaxVax Company Information
    • 7.7.2 PaxVax Business Overview
    • 7.7.3 PaxVax Oral Cholera Vaccine Sales, Revenue and Gross Margin (2020-2025)
    • 7.7.4 PaxVax Oral Cholera Vaccine Products Offered
    • 7.7.5 PaxVax Recent Development

8 Oral Cholera Vaccine Manufacturing Cost Analysis

  • 8.1 Oral Cholera Vaccine Key Raw Materials Analysis
    • 8.1.1 Key Raw Materials
    • 8.1.2 Key Suppliers of Raw Materials
  • 8.2 Proportion of Manufacturing Cost Structure
  • 8.3 Manufacturing Process Analysis of Oral Cholera Vaccine
  • 8.4 Oral Cholera Vaccine Industrial Chain Analysis

9 Marketing Channel, Distributors and Customers

  • 9.1 Marketing Channel
  • 9.2 Oral Cholera Vaccine Distributors List
  • 9.3 Oral Cholera Vaccine Customers

10 Oral Cholera Vaccine Market Dynamics

  • 10.1 Oral Cholera Vaccine Industry Trends
  • 10.2 Oral Cholera Vaccine Market Drivers
  • 10.3 Oral Cholera Vaccine Market Challenges
  • 10.4 Oral Cholera Vaccine Market Restraints

11 Research Findings and Conclusion

12 Appendix

  • 12.1 Research Methodology
    • 12.1.1 Methodology/Research Approach
      • 12.1.1.1 Research Programs/Design
      • 12.1.1.2 Market Size Estimation
      • 12.1.1.3 Market Breakdown and Data Triangulation
    • 12.1.2 Data Source
      • 12.1.2.1 Secondary Sources
      • 12.1.2.2 Primary Sources
  • 12.2 Author Details
  • 12.3 Disclaimer